PPFIA3
protein-codingPTPRF interacting protein alpha 3, the group of Sterile alpha motif domain containing
Gene summary
The protein encoded by this gene is a member of the LAR protein-tyrosine phosphatase-interacting protein (liprin) family. Liprins interact with members of LAR family of transmembrane protein tyrosine phosphatases, which are known to be important for axon guidance and mammary gland development. Liprin family protein has been shown to localize phosphatase LAR to cell focal adhesions and may be involved in the molecular organization of presynaptic active zones. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~31.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:1040014
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:1040014
Submitter: G2P
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PPFIA3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_003660.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 14 | 1 | 15 | |||
| missense | 2 | 10 | 165 | 2 | 179 | |
| nonsense | 2 | 2 | 5 | 9 | ||
| start loss | 0 | |||||
| frameshift | 2 | 5 | 4 | 11 | ||
| splice donor/acceptor (+/-2bp) | 2 | 4 | 6 | |||
| Total | 6 | 19 | 178 | 16 | 1 | 220 |
Highest pathogenic variant AF is 0.0000051341103
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_003651.1 | 28 | MANE Select | |
| Ensembl | ENSP00000335614.3 | 28 | MANE Select | |
| Ensembl | ENSP00000473622.1 | 27 | Standard | |
| Ensembl | ENSP00000473621.1 | 3 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| ppfia3 | Danio rerio | Structure: intersegmental vessel Quality: malformed abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Neuronal System
- Glutamate Neurotransmitter Release Cycle
- Dopamine Neurotransmitter Release Cycle
- Acetylcholine Neurotransmitter Release Cycle
- Neurotransmitter release cycle
Biological Process
- neurotransmitter secretion
- synaptic vesicle docking
- regulation of short-term neuronal synaptic plasticity
Molecular Function
- protein binding
Cellular Component
- acrosomal vesicle
- cytosol
- presynaptic active zone
- presynaptic active zone cytoplasmic component
- epididymosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000334186
- Coding exons
- 28
- Length
- 31638
- Individuals with no LoFs
- 125731
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 4
- Defined
- 125735
- p
- 0.0000159
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 5.49 | 311 | 727 | 0.428 | 0.0000436 | 7622 |
| Missense (PolyPhen) | 84 | 277.74 | 0.30244 | 2748 | ||
| Synonymous | 1.42 | 272 | 304 | 0.896 | 0.0000172 | 2470 |
| Loss of Function | 7.07 | 3 | 64.1 | 0.0468 | 0.00000318 | 715 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000027 | 0.000026 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May regulate the disassembly of focal adhesions. May localize receptor-like tyrosine phosphatases type 2A at specific sites on the plasma membrane, possibly regulating their interaction with the extracellular environment and their association with substrates. {ECO:0000269|PubMed:9624153}.;
Recessive Scores
- pRec
- 0.111
Intolerance Scores
- LoFtool
- 0.0112
- RVIS EVS
- -1.06
- RVIS percentile EVS
- 7.48
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.927
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |